Seeking Alpha's Stephen Simpson believes that NVDQ continues to look like a rare med-tech story with both very strong and large addressable markets. (see further comments at Seeking Alpha). Simpson has no position in NVDQ but announces that he "may initiate a long position in NVDQ over the next 72 hours."
Institutions are jumping on board. They see the same monopoly and high value added to a multibillion dollar market similar to ISRG back in 2003. Expect Institution ownership to jump from 50's to 80's over the next year or two.